ReproCELL Incorporated (TYO:4978)

ReproCELL Statistics

Total Valuation

ReproCELL has a market cap or net worth of JPY 15.06 billion. The enterprise value is 9.31 billion.

Market Cap	15.06B
Enterprise Value	9.31B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

ReproCELL has 94.69 million shares outstanding. The number of shares has increased by 6.47% in one year.

Current Share Class	94.69M
Shares Outstanding	94.69M
Shares Change (YoY)	+6.47%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.47%
Owned by Institutions (%)	-2.05%
Float	91.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.72
PB Ratio	1.74
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-33.35
EV / Sales	3.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-29.82

Financial Position

The company has a current ratio of 11.09

Current Ratio	11.09
Quick Ratio	10.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.20% and return on invested capital (ROIC) is -3.79%.

Return on Equity (ROE)	-3.20%
Return on Assets (ROA)	-3.51%
Return on Invested Capital (ROIC)	-3.79%
Return on Capital Employed (ROCE)	-6.02%
Weighted Average Cost of Capital (WACC)	7.43%
Revenue Per Employee	26.59M
Profits Per Employee	-2.82M
Employee Count	99
Asset Turnover	0.28
Inventory Turnover	4.49

Taxes

Income Tax	-56.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.82% in the last 52 weeks. The beta is 0.58, so ReproCELL's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-22.82%
50-Day Moving Average	155.54
200-Day Moving Average	174.61
Relative Strength Index (RSI)	48.97
Average Volume (20 Days)	1,230,240

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ReproCELL had revenue of JPY 2.63 billion and -279.00 million in losses. Loss per share was -2.95.

Revenue	2.63B
Gross Profit	1.33B
Operating Income	-528.00M
Pretax Income	-335.00M
Net Income	-279.00M
EBITDA	-466.00M
EBIT	-528.00M
Loss Per Share	-2.95

Balance Sheet

The company has 5.75 billion in cash and n/a in debt, with a net cash position of 5.75 billion or 60.73 per share.

Cash & Cash Equivalents	5.75B
Total Debt	n/a
Net Cash	5.75B
Net Cash Per Share	60.73
Equity (Book Value)	8.67B
Book Value Per Share	91.61
Working Capital	5.96B

Cash Flow

In the last 12 months, operating cash flow was -205.00 million and capital expenditures -107.00 million, giving a free cash flow of -312.00 million.

Operating Cash Flow	-205.00M
Capital Expenditures	-107.00M
Free Cash Flow	-312.00M
FCF Per Share	-3.30

Margins

Gross margin is 50.49%, with operating and profit margins of -20.06% and -10.60%.

Gross Margin	50.49%
Operating Margin	-20.06%
Pretax Margin	-12.73%
Profit Margin	-10.60%
EBITDA Margin	-17.71%
EBIT Margin	-20.06%
FCF Margin	n/a

Dividends & Yields

ReproCELL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.47%
Shareholder Yield	-6.47%
Earnings Yield	-1.85%
FCF Yield	-2.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 28, 2013. It was a forward split with a ratio of 5.

Last Split Date	Aug 28, 2013
Split Type	Forward
Split Ratio	5

Scores

ReproCELL has an Altman Z-Score of 13.5 and a Piotroski F-Score of 2.

Altman Z-Score	13.5
Piotroski F-Score	2